Savara
SVRA
#6157
Rank
S$1.41 B
Marketcap
S$6.87
Share price
-1.19%
Change (1 day)
53.47%
Change (1 year)

Earnings for Savara (SVRA)

Earnings in 2026 (TTM): -S$0.17 Billion

According to Savara's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -S$0.16 Billion a decrease over its 2024 earnings that were of -S$0.13 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Savara from 2002 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$0.17 Billion9.59%
2025 -S$0.16 Billion23.94%
2024 -S$0.13 Billion75.29%
2023 -S$69.74 Million43.38%
2022 -S$48.64 Million-11.31%
2021 -S$54.85 Million-13.3%
2020 -S$63.26 Million-36.53%
2019 -S$99.67 Million13.76%
2018 -S$87.62 Million105.54%
2017 -S$42.63 Million34.11%
2016 -S$31.79 Million-37.43%
2015 -S$50.8 Million38.81%
2014 -S$36.6 Million33.62%
2013 -S$27.39 Million38.49%
2012 -S$19.78 Million24.59%
2011 -S$15.88 Million-36.5%
2010 -S$25 Million-3.14%
2009 -S$25.81 Million-23.28%
2008 -S$33.64 Million8.52%
2007 -S$31 Million-34.14%
2006 -S$47.07 Million184.43%
2005 -S$16.55 Million90.75%
2004 -S$8.68 Million190.35%
2003 -S$2.99 Million11.64%
2002 -S$2.68 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-S$0.3 Billion 76.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-S$23.15 Million-85.98%๐Ÿ‡บ๐Ÿ‡ธ USA